Figure 3.

Comparisons of sclerostin serum levels in ankylosing spondylitis (AS) patients with C-reactive protein (CRP) < 5 mg/dL and CRP ≥ 5 mg/dL 12 months after anti-TNF therapy and in healthy controls.

Saad et al. Arthritis Research & Therapy 2012 14:R216   doi:10.1186/ar4055
Download authors' original image